By BullScreen Editorial Team 
Godrej Agrovet Limited reported a strong set of Q4 results 2026, supported by robust growth in its animal nutrition and oil palm businesses, while improved operational efficiency boosted overall profitability.
The company’s consolidated revenue for FY26 rose 9.1% year-on-year to ₹10,233 crore, marking the first time it crossed the ₹10,000 crore revenue mark. Reported EBITDA increased 12.8% to ₹969 crore, while profit after tax climbed 10.4% to ₹445 crore.
For Q4 results 2026, revenue grew 9.3% to ₹2,333 crore. Quarterly EBITDA jumped 29.5% to ₹207 crore, while reported net profit surged 54.7% year-on-year to ₹102 crore. Normalized PAT stood at ₹74 crore, up 11.3%.
The company said strong execution in the animal nutrition segment remained a major growth driver. Segment revenue in Q4 rose 10.8% to ₹1,270 crore, while profit increased 56.8% to ₹103 crore as feed volumes expanded sharply. Oil palm also delivered strong yearly growth, with FY26 segment revenue rising 42.4% to ₹1,908 crore.
Godrej Agrovet also improved its balance sheet efficiency during FY26. Average net working capital days dropped to 25 from 39 a year earlier, helping return on capital employed improve to 20% from 16%.
However, the dairy and crop care businesses remained under pressure due to higher procurement costs and adverse weather conditions. Creamline Dairy’s Q4 EBITDA declined 42%, while crop care profit fell nearly 49%.
Meanwhile, subsidiary Astec LifeSciences posted a major turnaround, achieving EBITDA break-even after reporting losses in the previous fiscal year.
Investors are also tracking the company’s ongoing digital transformation under Project Rise, alongside its ESG initiatives, including a 12.4% reduction in greenhouse gas emissions and increased renewable energy usage across operations.
| Metric | Q4 FY26 | YoY Change |
|---|---|---|
| Revenue | ₹2,333 Crore | ↑ 9.3% |
| EBITDA | ₹207 Crore | ↑ 29.5% |
| Normalized EBITDA | ₹173 Crore | ↑ 8.5% |
| Net Profit (PAT) | ₹102 Crore | ↑ 54.7% |
| Normalized PAT | ₹74 Crore | ↑ 11.3% |
| Animal Nutrition Revenue | ₹1,270 Crore | ↑ 10.8% |
| Animal Nutrition Profit | ₹103 Crore | ↑ 56.8% |
| Metric | FY26 | YoY Change |
|---|---|---|
| Revenue from Operations | ₹10,233 Crore | ↑ 9.1% |
| EBITDA | ₹969 Crore | ↑ 12.8% |
| Profit Before Tax (PBT) | ₹602 Crore | ↑ 20.4% |
| Profit After Tax (PAT) | ₹445 Crore | ↑ 10.4% |
| Net Working Capital Days | 25 Days | Improved from 39 Days |
| Return on Capital Employed (ROCE) | 20% | Up from 16% |
| Oil Palm Revenue | ₹1,908 Crore | ↑ 42.4% |
| Oil Palm Profit | ₹384 Crore | ↑ 67.9% |
| Metric | FY26 Update | Key Insight |
|---|---|---|
| Animal Nutrition | Volume up 11.6% | Strong demand and feed growth |
| Oil Palm | CPO realization at ₹112,781/MT | Higher pricing boosted margins |
| Crop Care | Profit down 27.2% | Weather and inventory pressure |
| Creamline Dairy | EBITDA down 33% | High milk procurement costs |
| Astec LifeSciences | EBITDA break-even achieved | Major operational turnaround |
| Renewable Energy Usage | 78.9% of total power mix | Strong ESG focus |
| GHG Emission Reduction | ↓ 12.4% | Progress toward FY35 target |
Source: https://www.bseindia.com/xml-data/corpfiling/AttachHis/db9d1eb0-8b3b-42a8-bfcc-c3a193a5c4e4.pdf